Glycopyrrolate Injection
Product Images NDC 71872-7094

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Molecular Structure (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 01)

FDA Label Image

5 mL Vial Label (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 06)

5 mL Vial Label (3f3b363b Fe6d 4dee 89bd C2ca992dcf49 06)
This is a description of Glycopyrrolate Injection, USP which comes in a 5 L Multiple Dose Vial, and is used for Intramuscular or Intravenous administration. It contains Benzyl Alcohol as a preservative and should be stored at a temperature between 20°C to 25°C. The product is manufactured by GRS Mendam or STV, and its dosage can be found in the package insert.*
FDA Label Image

Pdp (7094)

Pdp (7094)
This is a description of Glycopyrrolate Injection, USP in a 1mg/5mL (0.2mg/mL) 5 mL single-dose vial, containing benzyl alcohol as a preservative. It is for intramuscular or intravenous administration and has a pH adjusted with hydrochloric acid and/or sodium hydroxide when necessary. The usual dosage information can be found in the package insert. It is not suitable for use in newborns and should be stored at 20°C to 25°C (68°F to 77°F). The manufacturer is Wintas Limited and it is distributed by Ropackaged Medical Purchasing Solutions.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.